Stacey Voss

528 total citations
6 papers, 200 citations indexed

About

Stacey Voss is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Stacey Voss has authored 6 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Stacey Voss's work include Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS drug development and treatment (3 papers). Stacey Voss is often cited by papers focused on Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS drug development and treatment (3 papers). Stacey Voss collaborates with scholars based in United States and Germany. Stacey Voss's co-authors include Julie A. Lemm, Mengping Liu, Min Gao, Amy K. Sheaffer, Richard J. Colonno, Chaoqun Chen, Fiona McPhee, Jacques Friborg, Steven M. LeVine and Susan Chaniewski and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Stacey Voss

6 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stacey Voss United States	6	140	121	86	27	24	6	200
Frédéric Delouvroy Sweden	4	141 1.0×	97 0.8×	74 0.9×	50 1.9×	44 1.8×	5	210
Katrien Vermeiren Sweden	4	285 2.0×	222 1.8×	170 2.0×	40 1.5×	27 1.1×	5	346
Susan Chaniewski United States	7	265 1.9×	244 2.0×	161 1.9×	52 1.9×	15 0.6×	10	378
Keith Pietropaolo United States	12	194 1.4×	190 1.6×	211 2.5×	67 2.5×	34 1.4×	33	370
Annette von Delft United Kingdom	9	84 0.6×	92 0.8×	75 0.9×	74 2.7×	15 0.6×	15	252
Kathy Mosure United States	6	123 0.9×	103 0.9×	65 0.8×	54 2.0×	16 0.7×	9	197
Monica Bisbocci Italy	7	222 1.6×	165 1.4×	148 1.7×	106 3.9×	30 1.3×	10	336
John P. Maxwell United States	8	212 1.5×	154 1.3×	107 1.2×	127 4.7×	79 3.3×	23	409
Mieke De Wit Belgium	3	111 0.8×	97 0.8×	101 1.2×	49 1.8×	10 0.4×	6	268

Countries citing papers authored by Stacey Voss

Since Specialization

Citations

This map shows the geographic impact of Stacey Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Voss more than expected).

Fields of papers citing papers by Stacey Voss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Voss. The network helps show where Stacey Voss may publish in the future.

Co-authorship network of co-authors of Stacey Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Voss. A scholar is included among the top collaborators of Stacey Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Voss. Stacey Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Lemm, Julie A., Mengping Liu, Robert G. Gentles, et al.. (2014). Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase. Antimicrobial Agents and Chemotherapy. 58(6). 3485–3495. 47 indexed citations

2.

Ding, Min, Feng He, Thomas W. Hudyma, et al.. (2012). Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22(8). 2866–2871. 15 indexed citations

3.

Voss, Stacey, et al.. (2012). Effect on Hepatitis C Virus Replication of Combinations of Direct-Acting Antivirals, Including NS5A Inhibitor Daclatasvir. Antimicrobial Agents and Chemotherapy. 56(10). 5230–5239. 59 indexed citations

4.

Friborg, Jacques, Steven M. LeVine, Chaoqun Chen, et al.. (2012). Combinations of Lambda Interferon with Direct-Acting Antiviral Agents Are Highly Efficient in Suppressing Hepatitis C Virus Replication. Antimicrobial Agents and Chemotherapy. 57(3). 1312–1322. 41 indexed citations

5.

Gentles, Robert G., S. Sheriff, Brett R. Beno, et al.. (2011). Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 21(8). 2212–2215. 8 indexed citations

6.

Tenney, Daniel J., Gregory Yamanaka, Stacey Voss, et al.. (1997). Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase. Antimicrobial Agents and Chemotherapy. 41(12). 2680–2685. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact